TIDMACRL

RNS Number : 6771V

Accrol Group Holdings PLC

10 April 2019

10 April 2019

Accrol Group Holdings plc

("Accrol" or the "Group")

Senior Management Change: Appointment of Group Finance Director

Accrol, the UK's leading independent tissue converter, is pleased to announce that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect.

John joined the senior management team of Accrol in September 2018, as Group Financial Controller. Since then, he has gained a strong understanding of the business and its financials and has been closely involved in the latter stages of the turnaround process.

John qualified as a Chartered Accountant with KPMG and has nearly 20 years' experience as a senior finance executive, including over 10 years with Promethean World Limited (formerly Promethean World Plc), latterly as Group Financial Controller.

Hannah Argo, who was appointed Interim Chief Financial Officer whilst a search for a permanent replacement was undertaken, has completed her contract and leaves the Company today.

Dan Wright, Executive Chairman of Accrol, said: "We are delighted that John has accepted the role of permanent Group Finance Director. His knowledge and understanding of the Group, gained during an intense and difficult period for the Group, will allow him to hit the ground running. The Board has been thoroughly impressed with his contribution and commitment to the business over the last seven months and we look forward to working with him even more closely."

"On behalf of all the directors, I thank Hannah for stepping into the role of Interim CFO and for her work during this time."

The Board remains unchanged, comprising Dan Wright (Executive Chairman), Gareth Jenkins (Chief Executive Officer), Euan Hamilton (Non-Executive) and Simon Allport (Non-Executive).

 
For further information, please contact: 
 
Accrol Group Holdings plc 
Dan Wright, Executive Chairman              Tel: +44 (0) 1254 278 844 
Gareth Jenkins, Chief Executive Officer 
 
Zeus Capital Limited (Nominated Adviser 
 & Broker) 
Dan Bate / Andrew Jones                     Tel: +44 (0) 161 831 1512 
Dominic King / John Goold                   Tel: +44 (0) 203 829 5000 
 
Belvedere Communications Limited 
Cat Valentine (cvalentine@belvederepr.com)  Tel: +44 (0) 7715 769 078 
Keeley Clarke (kclarke@belvederepr.com)     Tel: +44 (0) 7967 816 525 
Llew Angus (langus@belvederpr.com)           Tel: +44 (0)7407 023 147

Notes to Editors

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. Accrol operates from three sites:

 
 --   A manufacturing, storage and distribution 
       facility in Blackburn; 
 --   A facial tissue plant, also in Blackburn; 
       and 
 --   A manufacturing, storage and distribution 
       facility in Leyland.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BOALLFIRSDIAIIA

(END) Dow Jones Newswires

April 10, 2019 02:01 ET (06:01 GMT)

Accrol (LSE:ACRL)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Accrol Charts.
Accrol (LSE:ACRL)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Accrol Charts.